These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 11576078)
1. Comparison of the effects of levocetirizine and loratadine on histamine-induced wheal, flare, and itch in human skin. Clough GF; Boutsiouki P; Church MK Allergy; 2001 Oct; 56(10):985-8. PubMed ID: 11576078 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of desloratadine and levocetirizine on histamine-induced wheal, flare and itch in human skin. Denham KJ; Boutsiouki P; Clough GF; Church MK Inflamm Res; 2003 Oct; 52(10):424-7. PubMed ID: 14520518 [TBL] [Abstract][Full Text] [Related]
3. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects. Grant JA; Riethuisen JM; Moulaert B; DeVos C Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924 [TBL] [Abstract][Full Text] [Related]
4. A comparison of levocetirizine and desloratadine in the histamine-induced wheal and flare response in human skin in vivo. Popov TA; Dumitrascu D; Bachvarova A; Bocsan C; Dimitrov V; Church MK Inflamm Res; 2006 Jun; 55(6):241-4. PubMed ID: 16955243 [TBL] [Abstract][Full Text] [Related]
5. [The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial]. Kłos K; Kruszewski J; Kruszewski R; Sułek K Pol Merkur Lekarski; 2006 Nov; 21(125):449-53. PubMed ID: 17345838 [TBL] [Abstract][Full Text] [Related]
6. Comparison of effects of 5 and 10 mg oral desloratadine and levocetirizine on histamine-induced wheal and flare response in healthy volunteers. Bulca S; Bayramgürler D; Odyakmaz Demirsoy E; Yavuz M; Sikar Aktürk A; Bilen N; Kıran R J Dermatolog Treat; 2013 Dec; 24(6):473-6. PubMed ID: 23441762 [TBL] [Abstract][Full Text] [Related]
7. A double-blind, single-dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratadine versus placebo: suppression of histamine-induced wheal and flare response for 24 h in healthy male subjects. Grant JA; Danielson L; Rihoux JP; DeVos C Allergy; 1999 Jul; 54(7):700-7. PubMed ID: 10442525 [TBL] [Abstract][Full Text] [Related]
8. [Inhibition of histamine-induced wheel after a recommended single dose administration of 10 mg cetirizine, 5 mg desloratadine, 120 i 180 mg fexofenadine, 5 mg levocetirizine and 10 mg loratadine--a randomized, double-blind, placebo controlled trial]. Kruszewski J; Kłos K; Sułek K Pol Merkur Lekarski; 2006 Nov; 21(125):443-8. PubMed ID: 17345837 [TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, crossover comparison among cetirizine, levocetirizine, and ucb 28557 on histamine-induced cutaneous responses in healthy adult volunteers. Devalia JL; De Vos C; Hanotte F; Baltes E Allergy; 2001 Jan; 56(1):50-7. PubMed ID: 11167352 [TBL] [Abstract][Full Text] [Related]
10. Cetirizine and loratadine: a comparison using the ED50 in skin reactions. Ramboer I; Bumtbacea R; Lazarescu D; Radu JR J Int Med Res; 2000; 28(2):69-77. PubMed ID: 10898119 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of allergen-induced wheal and flare reactions by levocetirizine and desloratadine. Frossard N; Strolin-Benedetti M; Purohit A; Pauli G Br J Clin Pharmacol; 2008 Feb; 65(2):172-9. PubMed ID: 17953719 [TBL] [Abstract][Full Text] [Related]
12. Effects of acrivastine, loratadine and cetirizine on histamine-induced wheal and flare responses. Bayramgürler D; Bilen N; Apaydýn R; Altintaş L; Sal G; Dökmeci S; Utkan T Clin Exp Dermatol; 1999 Sep; 24(5):407-11. PubMed ID: 10564333 [TBL] [Abstract][Full Text] [Related]
13. Comparative wheal and flare study of mizolastine vs terfenadine, cetirizine, loratadine and placebo in healthy volunteers. Rosenzweig P; Caplain H; Chaufour S; Ulliac N; Cabanis MJ; Thebault JJ Br J Clin Pharmacol; 1995 Nov; 40(5):459-65. PubMed ID: 8703650 [TBL] [Abstract][Full Text] [Related]
14. Comparative activity of cetirizine and desloratadine on histamine-induced wheal-and-flare responses during 24 hours. Purohit A; Melac M; Pauli G; Frossard N Ann Allergy Asthma Immunol; 2004 Jun; 92(6):635-40. PubMed ID: 15237765 [TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacology of the H1-receptor antagonists cetirizine and loratadine in children. Simons FE; Johnston L; Simons KJ Pediatr Allergy Immunol; 2000 May; 11(2):116-9. PubMed ID: 10893015 [TBL] [Abstract][Full Text] [Related]
16. Suppression of the histamine-induced wheal and flare response by fexofenadine HCl 60 mg twice daily, loratadine 10 mg once daily and placebo in healthy Japanese volunteers. Boyle J; Ridout F; Meadows R; Johnsen S; Hindmarch I Curr Med Res Opin; 2005 Sep; 21(9):1495-503. PubMed ID: 16197669 [TBL] [Abstract][Full Text] [Related]
17. Activity of ebastine (10 and 20 mg) and cetirizine at 24 hours of a steady state treatment in the skin of healthy volunteers. Frossard N; Benabdesselam O; Purohit A; Mounedji N; Pauli G Fundam Clin Pharmacol; 2000; 14(4):409-13. PubMed ID: 11030449 [TBL] [Abstract][Full Text] [Related]
18. [Comparative activity of antihistamines on area under dose-response curve from histamine-induced wheal and flare responses in human skin]. Wang RQ; Zhang HY Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Dec; 26(6):634-8. PubMed ID: 15663222 [TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy of wheal-and-flare suppression among various non-sedating antihistamines and the pharmacologic insights to their efficacy. Roongapinun S; Wajajamreon S; Fooanant S J Med Assoc Thai; 2004 May; 87(5):551-6. PubMed ID: 15222528 [TBL] [Abstract][Full Text] [Related]
20. A double dose of levocetirizine leads to better control of histamine-induced flare, wheal and itch in healthy donors. Tanizaki H; Nakamizo S; Nakahigashi K; Miyachi Y; Kabashima K Pharmacology; 2013; 92(1-2):71-4. PubMed ID: 23942038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]